Literature DB >> 15799003

Fucoidan inhibits the development of proteinuria in active Heymann nephritis.

Quanbin Zhang1, Ning Li, Tingting Zhao, Huimin Qi, Zuhong Xu, Zhien Li.   

Abstract

Fucoidan, the sulphated polysaccharide extracted from brown seaweed, has various biological activities. The effect of fucoidan on the formation of proteinuria and renal functions in active Heymann nephritis was investigated in this study. Active Heymann nephritis was induced by administering brush border protein of rat proximal uriniferous tubules (FX1A). Fucoidan was administered by oral intubation to Heymann nephritis rats at three doses (50, 100 and 200 mg/kg) once daily for 4 weeks. The elevated urinary protein excretion and plasma creatinine due to the induction of Heymann nephritis were significantly reduced by fucoidan at doses of 100 and 200 mg/kg. The results indicated that fucoidan has a renoprotective effect on active Heymann nephritis and is a promising therapeutic agent for nephritis. Copyright (c) 2005 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15799003     DOI: 10.1002/ptr.1623

Source DB:  PubMed          Journal:  Phytother Res        ISSN: 0951-418X            Impact factor:   5.878


  9 in total

Review 1.  Important determinants for fucoidan bioactivity: a critical review of structure-function relations and extraction methods for fucose-containing sulfated polysaccharides from brown seaweeds.

Authors:  Marcel Tutor Ale; Jørn D Mikkelsen; Anne S Meyer
Journal:  Mar Drugs       Date:  2011-10-24       Impact factor: 6.085

Review 2.  Therapies from fucoidan; multifunctional marine polymers.

Authors:  Janet Helen Fitton
Journal:  Mar Drugs       Date:  2011-09-30       Impact factor: 6.085

Review 3.  Marine polysaccharides from algae with potential biomedical applications.

Authors:  Maria Filomena de Jesus Raposo; Alcina Maria Bernardo de Morais; Rui Manuel Santos Costa de Morais
Journal:  Mar Drugs       Date:  2015-05-15       Impact factor: 5.118

4.  The Structure and Nephroprotective Activity of Oligo-Porphyran on Glycerol-Induced Acute Renal Failure in Rats.

Authors:  Jing Wang; Yun Hou; Delin Duan; Quanbin Zhang
Journal:  Mar Drugs       Date:  2017-05-09       Impact factor: 5.118

5.  Oligo-fucoidan prevents renal tubulointerstitial fibrosis by inhibiting the CD44 signal pathway.

Authors:  Cheng-Hsien Chen; Yuh-Mou Sue; Chung-Yi Cheng; Yen-Cheng Chen; Chung-Te Liu; Yung-Ho Hsu; Pai-An Hwang; Nai-Jen Huang; Tso-Hsiao Chen
Journal:  Sci Rep       Date:  2017-01-18       Impact factor: 4.379

Review 6.  Fucoidan: structure and bioactivity.

Authors:  Bo Li; Fei Lu; Xinjun Wei; Ruixiang Zhao
Journal:  Molecules       Date:  2008-08-12       Impact factor: 4.411

7.  The protective effect of fucoidan in rats with streptozotocin-induced diabetic nephropathy.

Authors:  Jing Wang; Huaide Liu; Ning Li; Quanbin Zhang; Hong Zhang
Journal:  Mar Drugs       Date:  2014-05-30       Impact factor: 5.118

8.  Toxicological Evaluation of Low Molecular Weight Fucoidan in Vitro and in Vivo.

Authors:  Pai-An Hwang; Ming-De Yan; Hong-Ting Victor Lin; Kuan-Lun Li; Yen-Chang Lin
Journal:  Mar Drugs       Date:  2016-06-24       Impact factor: 5.118

9.  Fucoidan elevates surface organic cation transporter 2 expression via upregulation of protein kinase A in uric acid nephropathy.

Authors:  Xinlin Wu; Miansheng Yan; Taoli Liu; Jiantang Liao; Jianqing Zhang; Shuqing Chen; Wei Deng; Shijun Zhang; Baoguo Sun; Houming Zhou; Bin Ke
Journal:  Exp Ther Med       Date:  2017-08-30       Impact factor: 2.447

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.